Search Results 441-450 of 16955 for rbc

1. Avatrombopag for the Treatment of Thrombocytopenia in Adults Scheduled for a Surgical Procedure - Mayo Clinic

   ... red blood cells are permitted. Subject is unable to temporarily withhold anticoagulant or antiplatelet therapy per local standard of care prior to the ...

2. A Phase 3 Randomized, Placebo-controlled, Double-blind Study of Niraparib in Combination with Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Subjects with Metastatic Prostate Cancer - Mayo Clinic

   A transfusion (platelets or red blood cells); · Hematopoietic growth factors; · An investigational agent for prostate cancer; · Major surgery (sponsor should be ...

3. A Study to Determine the Safety and Effectiveness of Re-Establishing Flow Via Drug Coated Balloon for the Treatment Of Urethral Stricture Disease - Mayo Clinic

   Invisible hematuria (or significant microscopic hematuria; i.e., hematuria of ≥ 3 RBC's/HPF) that may be caused by a clinically significant disease unless ...

4. A Study to Confirm the Effectiveness and Safety of Terlipressin for Treatment of Hepatorenal Syndrome Type 1 - Mayo Clinic

   Tubular epithelial casts, heme granular casts, hematuria or microhematuria (greater than 50 red blood cells per high power field in the absence of recent ...

5. Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective Procedure - Mayo Clinic

   However packed red blood cells are permitted. Heparin, warfarin, nonsteroidal anti-inflammatory drugs (NSAID), aspirin, verapamil, and antiplatelet therapy ...

6. Temozolomide and Irinotecan Hydrochloride with or without Bevacizumab in Treating Young Patients with Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumors - Mayo Clinic

   Hemoglobin ≥ 8.0 gm/dL (may receive packed red blood cell [PRBC] transfusions); Creatinine clearance or radioisotope glomerular filtration rate (GFR) ≥ 70 ...

7. A Study to Evaluate the Safety and Efficacy of ABT-494 for Induction and Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis - Mayo Clinic

   ... RBC or higher on the current dosing regimen), injectable MTX (≥ 15 mg/week subcutaneous [SC] or intramuscular), or tacrolimus (for subjects in Japan and ...

8. A Study of Napabucasin (BBI-608) in Combination With FOLFIRI in Adult Patients With Previously Treated Metastatic Colorectal Cancer - Mayo Clinic

   Must not have required transfusion of red blood cells within 1 week of baseline Hgb assessment. Must have total bilirubin ≤ 1.5 × institutional ULN [≤ 2.0 ...

9. A Phase 3, randomized, open-label, controlled study comparing the efficacy and safety of zanidatamab to trastuzumab, each in combination with physician’s choice chemotherapy, for the treatment of participants with metastatic HER2-positive breast cancer - Mayo Clinic

   Hemoglobin ≥ 8 g/dL; participants with chronic anemia (other than autoimmune hemolytic anemia) that is supported by intermittent red blood cell transfusions ...

10. Hemangioma - Symptoms and causes - Mayo Clinic

    This red mark on a baby's skin looks like a rubbery bump or flat red mark and is made up of extra blood vessels in the skin. It generally goes away by age ...